12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga · 2d ago
Gainers
- IO Biotech (NASDAQ:IOBT) stock rose 52.5% to $2.76 during Monday's pre-market session. The company's market cap stands at $119.2 million.
- Entero Therapeutics (NASDAQ:ENTO) stock increased by 51.49% to $0.55. The company's market cap stands at $1.7 million.
- Bluejay Diagnostics (NASDAQ:BJDX) shares increased by 24.26% to $1.74. The market value of their outstanding shares is at $2.0 million. The company's, Q2 earnings came out 2 days ago.
- Salarius Pharmaceuticals (NASDAQ:SLRX) stock rose 21.4% to $0.61. The market value of their outstanding shares is at $1.0 million.
- Tilray Brands (NASDAQ:TLRY) shares moved upwards by 18.69% to $0.77. The company's market cap stands at $712.6 million.
- LENZ Therapeutics (NASDAQ:LENZ) stock moved upwards by 13.4% to $39.33. The market value of their outstanding shares is at $989.1 million.
Losers
- VSee Health (NASDAQ:VSEE) stock fell 55.3% to $0.59 during Monday's pre-market session. The market value of their outstanding shares is at $20.8 million.
- Humacyte (NASDAQ:HUMA) shares fell 10.89% to $2.21. The company's market cap stands at $384.6 million. As per the press release, Q2 earnings came out today.
- Silexion Therapeutics (NASDAQ:SLXN) stock fell 10.7% to $7.35. The market value of their outstanding shares is at $4.7 million.
- Exicure (NASDAQ:XCUR) shares fell 9.4% to $6.75. The market value of their outstanding shares is at $47.0 million. As per the press release, Q2 earnings came out yesterday.
- Owens & Minor (NYSE:OMI) stock declined by 8.33% to $6.5. The company's market cap stands at $543.1 million. The company's, Q2 earnings came out today.
- Replimune Group (NASDAQ:REPL) stock fell 7.76% to $4.88. The market value of their outstanding shares is at $412.9 million. The company's, Q1 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.